Methods and compounds for treating brain amyloidosis
AssigneesEvotec NeuroSciences GmbH, UniversitäT ZüRich
InventorsRoger Nitsch, Johannes Pohlner, Axel Wollmer, Hasan Mohajeri
Life of this patent
Estimating the term…
Abstract
The present invention discloses the use of (i) a fragment of the amyloid precursor protein (APP); or, (ii) a derivative of (i); or, (iii) a functional mimetic of (i) or (ii), in the preparation of a medicament for modulating CNS levels and/or activity of a member of the neprilysin family.
Claims14
1-38. (canceled)
A method of treating a neurodegenerative disorder, wherein the neurodegenerative disorder is brain amyloidosis or Alzheimer's disease, comprising increasing neutral endopeptidase-24.11 activity in a patient by administering to the patient a medicament containing
- i) a fragment of the amyloid precursor protein,
- ii) a derivative of the amyloid precursor protein obtained by varying the amino acid sequence of the fragment, or
- iii) a functional mimetic of the fragment or the derivative.
Dependencies are inferred from the claim text.